Microparticle Activation Buffer. 2 different clones are available. Clone Catalog # 1 L B2010003L 100 mL B2010003S Catalog number: B2010003L B2010003S Lot number: Batch Dependent Expiration date: Batch Dependent Size: 100 mL and bulk Storage: 2-8°C Buffer: pH 6.1 Microparticle Activation Buffer is a biotechnology-grade reagent formulated to prepare latex and magnetic microparticles for surface functionalization and conjugation. Supplied in two formats—1 L (Catalog #B2010003L) and 100 mL (Catalog #B2010003S)—this buffer maintains optimal conditions for activating carboxyl or other reactive groups on particle surfaces. With a pH of 6.1, it supports efficient coupling reactions while preserving particle integrity and dispersion. Researchers and assay developers working in immunodiagnostics, biosensor development, and particle-based ELISAs rely on activation buffers to ensure consistent and reproducible conjugation of antibodies, proteins, or ligands to microparticles. This buffer is filtered through 0.22 µm membranes and prepared with ultrapure water to ensure high purity and minimal background interference. Stored at 2–8°C, it integrates seamlessly into manual and automated workflows for high-throughput assay development and custom reagent formulation. Key benefits: Optimized for activating latex and magnetic microparticles Available in 100 mL and 1 L formats for scalable use pH 6.1 buffer supports efficient surface functionalization Filtered through 0.22 µm membranes using ultrapure water Stored at 2–8°C for long-term reagent stability Products are for in vitro research use only (RUO). References George C, Matsha TE, Korf M, Zemlin AE, Erasmus RT, Kengne AP. The agreement between fasting glucose and markers of chronic glycaemic exposure in individuals with and without chronic kidney disease: a cross-sectional study. BMC Nephrol . 2020 Jan 30;21(1):32. Ghazizadeh H, Rezaei M, Avan A, Fazilati M, Pasdar A, Tavallaie S, Kazemi E, Seyedi SMR, Ferns GA, Azimi-Nezhad M, Ghayour-Mobarhan M. ssociation between serum cell adhesion molecules with hs-CRP, uric acid and VEGF genetic polymorphisms in subjects with metabolic syndrome. Mol Biol Rep . 2020 Feb;47(2):867-875. Moutachakkir M, Lamrani Hanchi A, Baraou A, Boukhira A, Chellak S. Immunoanalytical characteristics of C-reactive protein and high sensitivity C-reactive protein. Ann Biol Clin (Paris) . 2017 Apr 1;75(2):225-229. Veltman EM, Lamers F, Comijs HC, Stek ML, van der Mast RC, Rhebergen D. Inflammatory markers and cortisol parameters across depressive subtypes in an older cohort. J Affect Disord . 2018 Jul;234:54-58. Eto D, Tanaka R, Suzuki Y, Sato Y, Itoh H. Comparison of performance characteristics between high-performance liquid chromatography and latex agglutination turbidimetric immunoassay for therapeutic drug monitoring of zonisamide. J Clin Lab Anal . 2019 Sep;33(7):e22940.
